A.I. Virtanen Institute for Molecular Sciences - News

Even short-term exposure to ultra-fine particles at relatively low doses can lead to elevated cytokine levels, alter the expression of brain membrane drug transporter proteins, and affect gene expression in the olfactory bulb.

In the future, it may be possible to use microRNAs in the treatment of heart attack and ischemic stroke to help the tissue to grow new capillaries and to gain back its normal function.

Cerebrovascular disorders in the working-age population have become common in high-income countries. “In part, this is probably due to changes in lifestyles," said Docent Jukka Putaal at the XXII Nordic Stroke Society Congress in Kuopio.

The GeneT project seeks to enhance advanced manufacturing and use of gene therapy drugs in the academic environment.

Researchers at the University of Eastern Finland have identified plasma protein-based biomarkers capable of identifying adolescents at risk of developing mental health issues.

MSCA Doctoral Networks is a part of the EU Horizon programme. Funding is used to hire doctoral students for projects.

The MIRACLE project brings together unique data resources and expertise to provide novel multiomics based prediction models of atherosclerotic cardiovascular disease.

The XXII Nordic Stroke Society Congress will be held in Kuopio on 21–23 August and Kuopio Health Insights on 20–21 August.

Grants were awarded for PhD researchers and postdoctoral researchers for a research period abroad.

The Academy of Finland’s Research Council for Biosciences, Health and the Environment granted more than 5.2 million euros of funding to Academy Projects at the University of Eastern Finland.